MGT 401 SEU Strategic Management Case Study

User Generated

Vabhs6n

Business Finance

MGT 401

Saudi electronic university

MGT

Description

Students are advised to make their work clear and well presented, marks may be reduced for poor presentation. This includes filling your information on the cover page.

Avoid plagiarism (NO MATCHING RATIO)

All answered must be typed using Times New Roman (size 12, double-spaced) font. No pictures containing text will be accepted and will be considered plagiarism).

Read the case thoroughly and make a summary alongside reading Chapter 12 in your textbook before answering the questions of the assignment.

write references

Note. All references used should be listed by the end of your analysis, using the APA style.

Unformatted Attachment Preview

Kingdom of Saudi Arabia Ministry of Education Saudi Electronic University ‫المملكة العربية السعودية‬ ‫وزارة التعليم‬ ‫الجامعة السعودية اإللكترونية‬ College of Administrative and Financial Sciences Assignment 3 Strategic Management (MGT 401) Deadline: 04/12/2021 @ 23:59 Course Name: Strategic Management Student’s Name: Course Code: MGT401 Student’s ID Number: Semester: First CRN: Academic Year:2021-22 For Instructor’s Use only Instructor’s Name: Students’ Grade: Marks Obtained/Out of 5 Level of Marks: High/Middle/Low Instructions – PLEASE READ THEM CAREFULLY • • • • • • • • The Assignment must be submitted on Blackboard (WORD format only) via allocated folder. Assignments submitted through email will not be accepted. Students are advised to make their work clear and well presented, marks may be reduced for poor presentation. This includes filling your information on the cover page. Students must mention question number clearly in their answer. Late submission will NOT be accepted. Avoid plagiarism, the work should be in your own words, copying from students or other resources without proper referencing will result in ZERO marks. No exceptions. All answered must be typed using Times New Roman (size 12, double-spaced) font. No pictures containing text will be accepted and will be considered plagiarism). Submissions without this cover page will NOT be accepted. Assignment No 3 Learning Outcomes: 1. Distinguish between different types and levels of strategy and strategy implementation (Lo.3) 2. Gain insights into the strategy-making processes of different types of organizations (Lo.4) 3. Understand issues related to strategic competitive advantage in diversified organizations (Lo.6) From real national/international market, select any type of strategic alliance between two firms and answer the following questions: 1. Briefly introduce your chosen firms, partners of the strategic alliance (industry, nationality, size, market position…). (1Mark)- Max 150 words 2. What is the type of strategic alliance used by your chosen firms? Explain its different reasons. (1Mark) 3. What is the method used by the firms to manage their cultures after alliance? underline the pros and cons of this method. (1 Mark) 4. Is this strategic alliance successful? Justify. (1 Mark) 5. What recommendations can you give for the managers of these firms to improve their competitiveness? (1 mark) Note. All references used should be listed by the end of your analysis, using the APA style. Answers 9:28 PM Thu 2 Dec @ @ 82% < > AA Ims.seu.edu.sa + + EgyBest V Vidstre S Assignment... S Assignment... S Assignment... Bb Review Sub... X Originality R... S Discussion -... scussion -... Blackboard SafeAssign Originality Report (Current Semester - Stall Lesill)MGT-401: Strateg... . Assignment 3 · Submitted on Thu, Dec 02, 2021, 9:24 PM View Originality Report - Old Design Nouf Alaskar View Report Summary U INCLUDED SOURCES 12 entered medical testing against Nipah virus, HIV, and influenza (Mahase, 2020). (4 On the other hand, Lonza Group Company is a Swiss multina- tional chemicals and biotechnology firm, located in Basel. It has other fa- cilities in South Asia, North America and Europe. Lonza was founded in the late nineteenth-century. Biopharmaceutical and biotechnology com- panies rely on Lonza Company for product manufacturing and develop- ment and for custom production of detection systems, services for bio- sciences firms, biopharmaceuticals, and chemical synthesis capabilities Institutional database (2) 28 % 1) Student paper (Lonza, 2021). 5 Student paper Q2: Moderna Company and Lonza Group Company have formed a non- equity strategic collaboration. (5 A non-equity strategic alliance is formed when two or more businesses agree to combine their assets and capabilities. Moderna is pursuing a non-equity strategic cooperation with Lonza to get a production license for Moderna's Vaccine (mRNA-1273) Against Novel Coronavirus (Lanza 2021) Aconcerted effort will use lan. Internet (6) 21 % < Word Count: Submitted on: Submission UUID: Attachment UUID: 3 writerswizard IR 1,630 12/02/21 b86898be-Oa1c-a059-Ocad-15333b0a8298 4025195d-8753-3b22-77e6-655345012853 9:28 PM Thu 2 Dec @ @ 82% < > AA Ims.seu.edu.sa + + EgyBest V Vidstre S Assignment... S Assignment... S Assignment... Bb Review Sub... X Originality R... S Discussion -... scussion -... Blackboard SafeAssign Originality Report (Current Semester - Stall Lesill)MGT-401: Strateg... . Assignment 3 · Submitted on Thu, Dec 02, 2021, 9:24 PM View Originality Report - Old Design Nouf Alaskar View Report Summary INCLUDED SOURCES 12 Institutional database (2) 28 % against the new coronavirus SARS-CoV-2 in the near term as well as fu- ture production of other Moderna products (Moderna, 2020). Moderna intends to exploit Lonza's key competencies in technical assistance and production via the non-equity alliance. In the future, the non-equity collaboration with Lonza will enable large-scale manufacture of Moder- na's mRNA-1273 vaccine and additional Moderna products. Moderna is able to expand its manufacturing capacity without raising its manufactur- ing expenses via the use of agreements. The firms intend to construct production units for mRNA-1273 in Lonza's facilities across the country and Switzerland. 6 The technology transfer was planned to commence in June 2020, and the firms aimed to begin manufacturing the first mRNA- 1273 batches at Lonza in the United States in July of last year (Moderna, Student paper 5 Student paper 2020). Internet (6) 21 % < Q3: Following the strategic partnerships, both companies use incentive systems to manage their cultures. By describing desirable actions and at- Word Count: Submitted on: Submission UUID: Attachment UUID: 3 writerswizard IR 1,630 12/02/21 b86898be-Oa1c-a059-Ocad-15333b0a8298 4025195d-8753-3b22-77e6-655345012853 9:28 PM Thu 2 Dec @ @ 82% < > AA Ims.seu.edu.sa + + EgyBest V Vidstre S Assignment... S Assignment... S Assignment... Bb Review Sub... X Originality R... S Discussion -... scussion -... Blackboard SafeAssign Originality Report (Current Semester - Stall Lesill)MGT-401: Strateg... . Assignment 3 · Submitted on Thu, Dec 02, 2021, 9:24 PM View Originality Report - Old Design Nouf Alaskar View Report Summary INCLUDED SOURCES 12 Institutional database (2) 28 % Moderna leverages Lonza's global distribution network and engagement in technical advancements to assist in the future manufacture of mRNA- 1273 and other items. Companies agreed to set up production suites for mRNA-1273 in Lonza's plants in both Switzerland and the Unit- ed States as part of their agreement. The technology transfer to com- merce was completed in June last year, and the company began produc- tion of the mRNA 1273 first batches in July last year. Lonza's production capabilities complement Moderna's existing activities in the United States, which are ramping up in preparation for future clinical manufacture and marketing of mRNA-1273. Moderna's worldwide footprint and experience are vital as we grow at extraordinary speed, and this long-term strategic partnership arrangement will allow Moderna to expand by 10-fold (Price, Student paper 5 Student paper 2020). Internet (6) 21 % < Q5: In order to increase their competitiveness, management at both Mod- erna and Lonza companies might use a variety of strategies. Among the Word Count: Submitted on: Submission UUID: Attachment UUID: 3 writerswizard IR 1,630 12/02/21 b86898be-Oa1c-a059-Ocad-15333b0a8298 4025195d-8753-3b22-77e6-655345012853
Purchase answer to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer

View attached explanation and answer. Let me know if you have any questions.

Running Head: STRATEGIC MANAGEMENT: ASSIGNMENT 3

Strategic Management: Assignment 3
Student Name
Professor Name
Course title
Date of submission

1

STRATEGIC MANAGEMENT: ASSIGNMENT 3

2

Q1
Moderna Company and Lonza Group Corporation are two companies that have formed a
strategic alliances. Modern Company is a Cambridge, Massachusetts-based biotechnology and
pharmaceutical company focused on mRNA treatments and vaccines. MRNA vaccines induce an
immunological response by using a molecule copy referred to as messenger RNA (mRNA).
Moderna Company currently sells only one commercial product: the Moderna COVID-19
Vaccine. However, the firm has 23 therapy and vaccine candidates in development testing, with
15 of them having entered medical testing against Nipah virus, HIV, and influenza (Mahase,
2020).
On the other hand, Lonza Group Company is a Swiss multinational chemicals and
biotechnology firm, located in Basel. It has other facilities in South Asia, North America and
Europe. Lonza was founded in the late nineteenth-century. Biopharmaceutical and biotechnology
companies rely on Lonza Company for product manufacturing and development and for custom
production of detection systems, services for biosciences firms, biopharmaceuticals, and
chemical synthesis capabilities (Lonza, 2021).
Q2
Moderna Company and Lonza Group Company have formed a non-equity strategic
collaboration. A non-equity strategic alliance is formed when two or more businesses agree to
combine their assets and capabilities. Moderna is pursuing a non-equity strategic cooperation
with Lonza to get a production license for Moderna's Vaccine (mRNA-1273) Against Novel
Coronavirus (Lonza, 2021). A concerted effort will use Lonza's comprehensive expertise...


Anonymous
Just what I needed. Studypool is a lifesaver!

Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4

Related Tags